One Neil Woodford stock I’d buy with £2k and one I’d sell today

Rupert Hargreaves looks at the stocks in Neil Woodford’s portfolio and highlights the one he likes best.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Whenever I invest in a company, the first thing I always consider is the quality and track record of its management. And that’s why I would buy Neil Woodford favourite Non-Standard Finance (LSE: NSF), but sell Provident Financial (LSE: PFG). 

Backing management 

Non-Standard and Provident are both similar businesses. They provide short term high-cost credit to customers who might have been shut off from traditional lenders. 

For a long time, Provident was the leader in this field under the stewardship of former CEO John van Kuffeler. However, shortly after this transformational CEO left, the wheels started to come off. The new management tried to restructure the business by altering the way it collects outstanding credit. The result was chaos. Collections slumped from more than 70% to around 50%, and many employees left the business, taking their customers with them. Companies like Non-Standard benefitted from this exodus.

And now Non-Standard, which is led by none other than John van Kuffeler, is trying to capitalise on its rival’s problems. 

Unsolicited offer 

Non-Standard has made an unsolicited £1.3bn offer for the group, which is supported by shareholders on both sides. 

Neil Woodford and his former employer Invesco own the majority of both companies and they are pushing for the merger to go ahead. However, Provident is trying to de-rail van Kuffeler’s offer, and that’s why I’d sell Provident and invest £2k in Non-Standard today. 

Provident is several times larger than Non-Standard and, if the deal completes, it will leave the former’s shareholders owning the majority of the company. This isn’t the perfect outcome, but I think combining the two groups is the right decision. Van Kuffeler’s record shows that he knows how to run a business like Provident, and run it well, so I think he’s the best candidate for the job. 

On the other hand, Provident’s current management doesn’t seem to be cut out for the job. They’ve attacked Non-Standard’s offer, stating that it has “major strategic flaws, contains a number of misguided assumptions about the Provident business and includes future plans which we consider to be fraught with execution risk.”

Provident is also attacking Non-Standard’s share price performance. In a press release published today, Provident states “NSF’s share price has fallen on average 20% since its acquisitions and its share price has fallen 30% since it announced the issuance of new shares to acquire Everyday Loans.

This may be true, but considering Provident’s own share price is down more than 81% over the past three years, the attack seems a bit petty. 

The better buy 

All of the above leads me to conclude that Non-Standard is the better buy for investors today. 

The company might have underperformed over the past few months, but its experienced management team is worth backing, in my opinion. Van Kuffeler has an impressive track record of creating value for investors, and the combined Non-Standard/Provident should give him a stable platform to build on. 

Even if the deal doesn’t go ahead, I think the outlook for Non-Standard is bright as the business continues to build on is successes (and Provident’s failures). Without the merger, analysts believe the firm’s revenue will double over the next two years. Over the same period, analysts are expecting Provident’s revenues to flatline. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »